Zhengye Biotechnology Holding (ZYBT) Receivables - Net (2023 - 2025)
Zhengye Biotechnology Holding (ZYBT) posted quarterly Receivables - Net of $5.1 million for Q4 2025, down 51.61% year-over-year from $10.6 million in Q4 2024, and down 30.54% quarter-over-quarter from $7.4 million in Q2 2025.
Zhengye Biotechnology Holding (ZYBT) Receivables - Net (2023 - 2025) Analysis & Trends
Zhengye Biotechnology Holding (ZYBT) has reported Receivables - Net for 3 consecutive years, with $5.1 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Receivables - Net fell 51.61% year-over-year to $5.1 million; the TTM figure through Dec 2025 stood at $5.1 million (down 51.61% YoY), while the FY2025 annual figure was $5.2 million, down 50.13% from the prior year.
- Receivables - Net slipped to $5.1 million in Q4 2025 per ZYBT's latest filing, from $7.4 million in the prior quarter.
- Across five years, Receivables - Net topped out at $12.9 million in Q4 2023 and bottomed at $5.1 million in Q4 2025.
- Historically, Receivables - Net has averaged $9.0 million across 3 years, with a median of $9.0 million in 2024.
- Annual changes were most pronounced in 2024 — Receivables - Net fell 17.42% — and 2025, when it sank 51.61%.
- Zhengye Biotechnology Holding's Receivables - Net stood at $12.9 million in 2023, then decreased by 17.42% to $10.6 million in 2024, then tumbled by 51.61% to $5.1 million in 2025.
- Business Quant data shows ZYBT's Receivables - Net at $5.1 million in Q4 2025, $7.4 million in Q2 2025, and $10.6 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Zhengye Biotechnology Holding | 85.23 Mn | 77.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.15 Mn |
| Dec 31, 2025 | 5.15 Mn |
| Jun 30, 2025 | 7.41 Mn |
| Jun 30, 2025 | 7.41 Mn |
| Dec 31, 2024 | 10.64 Mn |
| Dec 31, 2024 | 10.64 Mn |
| Dec 31, 2023 | 12.89 Mn |
| Dec 31, 2023 | 12.89 Mn |